top of page
 |
|---|
CLINICAL STUDIES
EnLyte has been clinically shown to effectively address symptoms related to depression
Clinical Psychiatry
Case Report
NEWLY PUBLISHED!
A 22 Case Report Series on Children and Adolescents using Enlyte
"The occurrence of major depression is increasing in our pediatric population. Prior to the COVID-19 pandemic, the rate of major depression was 1% to 2% annually for patients up to age 13, with an increasing prevalence through adolescence...
Published in
The Journal of Clinical Psychiatry
330 Adult Patient, Randomized, Double-Blind Placebo-Controlled Study
Andrew Farah, MD